Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients

Rebecca Epperly(St. Jude Children's Research Hospital), Brandon M. Triplett(St. Jude Children's Research Hospital), Aimee C. Talleur(St. Jude Children's Research Hospital), MaCal Tuggle(St. Jude Children's Research Hospital), Ashok Srinivasan(St. Jude Children's Research Hospital), Ewelina Mamcarz(National Institutes of Health), Swati Naik(St. Jude Children's Research Hospital), Stephen Gottschalk(St. Jude Children's Research Hospital), Sarah Schell, Akshay Sharma(St. Jude Children's Research Hospital), Jean‐Yves Métais(National Institutes of Health), Ali Suliman(St. Jude Children's Research Hospital), Cheng Cheng(Jilin University), Ying Li(St. Jude Children's Research Hospital), Deqing Pei(St. Jude Children's Research Hospital), Amr Qudeimat(St. Jude Children's Research Hospital), Renee Madden(St. Jude Children's Research Hospital), Sujuan Huang(St. Jude Children's Research Hospital)

Transplantation and Cellular Therapy

February 10, 2022

Cited by 3

|Nature|2012|1.6k

|New England Journal of Medicine|2014|1.4k

|The Lancet Oncology|2009|1k

|Nature Genetics|2017|934

|The Lancet|2017|856

Related Papers